First patient dosed in long-term Alzheimer’s trial 06-Oct-2020 By Jenni Spinner Neurotrope has kicked off its ongoing Phase II study of Bryostatin-1 for treatment of Alzheimer’s disease, with the help of a $2.7m NIH grant.
Machine learning model forecasts Alzheimer’s-driven cognitive decline 21-Aug-2019 By Nick Taylor Computer model predicts worsening cognitive scores, opening door to the use of machine learning in the selection of participants in Alzheimer’s disease trials.